Biopsy Confirmed Glioma Recurrence Predicted by Multi-Modal Neuroimaging Metrics

Histopathological verification is currently required to differentiate tumor recurrence from treatment effects related to adjuvant therapy in patients with glioma. To bypass the complications associated with collecting neural tissue samples, non-invasive classification methods are needed to alleviate...

Descripción completa

Detalles Bibliográficos
Autores principales: Costabile, Jamie D., Thompson, John A., Alaswad, Elsa, Ormond, D. Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780506/
https://www.ncbi.nlm.nih.gov/pubmed/31450732
http://dx.doi.org/10.3390/jcm8091287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780506/
https://www.ncbi.nlm.nih.gov/pubmed/31450732
http://dx.doi.org/10.3390/jcm8091287

Ejemplares similares